Articles about Biotechnology – Page 4 of 4

Ex-Dendreon CEO starts healthcare investment fund Alpine BioVentures

by John Cook on September 3, 2013September 3, 2013 at 7:27 am

Former Dendreon CEO Mitch Gold has partnered with biotechnology stock researcher David Miller to create a new Seattle-based investment firm called Alpine BioVentures. The fund, which was started earlier this… Read More

Stem cell biology company Fate Therapeutics files for $69 million IPO

by John Cook on August 14, 2013August 14, 2013 at 8:24 am

Could this be another example of a startup that got away? Fate Therapeutics, which started in Seattle six years ago with backing from Arch Venture Partners and others, has filed… Read More

Nanostring IPO disappoints as shares fall 20% on first day

by Taylor Soper on June 26, 2013June 26, 2013 at 6:29 pm

It was a tough first day on the stock market for Seattle’s NanoString Technologies, with shares falling 19.4 percent on Wednesday as the stock closed at $8.06. The 138-person company, a maker of… Read More

Looking to commercialize cancer treatments, Seattle Genetics inks deal with Bayer valued up to $520M

by John Cook on June 25, 2013June 25, 2013 at 7:46 am

Seattle Genetics has agreed to license its antibody-drug conjugate technology to Bayer HealthCare, a deal that could be worth as much as $520 million if milestones ar met. Shares of Seattle Genetics… Read More

NanoString sets IPO range of $13-$15, plans to trade on Nasdaq under ticker NSTG

by John Cook on June 13, 2013June 13, 2013 at 7:56 am

Seattle’s NanoString Technologies today set the terms for its upcoming initial public offering, with plans to sell shares in the range of $13 to $15 per share. The 138-person company, a… Read More

BeatBio gets $2.5M for new ‘super fuel’ that boosts pumping power of heart muscles

by John Cook on April 16, 2013April 16, 2013 at 3:23 pm

BeatBio, a Seattle life sciences startup led by former Vulcan Capital managing director Michael Kranda and former VieVax CTO Gregory Mahairas, has raised $2.5 million in seed funding from CET… Read More

Theraclone raises $14M to ID rare human antibodies that could be used to fight disease

by John Cook on March 25, 2013March 25, 2013 at 7:13 am

Seattle biotechnology company Theraclone Sciences has raised an additional $8 million in equity financing and $6 million in debt, bringing total investment in its series B funding to $50 million.… Read More

This ag science startup just scored cash to develop the apple tree of the future

by John Cook on February 25, 2013February 25, 2013 at 8:00 am

We write about a lot of high-tech stuff here at GeekWire. But here’s a new company that’s bringing a high-tech twist to one of the region’s oldest industries: agriculture. Phytelligence… Read More

Blaze Bioscience raises $8.5M to help surgeons pinpoint cancer cells with ‘tumor paint’

by John Cook on February 22, 2013February 22, 2013 at 6:37 am

Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more easily identify cancer cells in the body. Total funding in… Read More

Former oil trader, Yankees part-owner invests in Kineta

by Taylor Soper on February 5, 2013February 5, 2013 at 2:15 pm

Seattle-based biotech upstart Kineta announced a new investment partnership with RLB Holdings, a Connecticut-based investment firm that partially owns the New York Yankees and is managed by a former Glencore international… Read More

Bill Gates backs cancer test startup to create a precise genomic tumor blueprint

by John Cook on January 21, 2013January 21, 2013 at 7:00 am

Microsoft co-founder Bill Gates is tossing his support behind a Cambridge, Massachusetts company by the name of Foundation Medicine which is developing new tests for cancer. Gates is among the… Read More

Paul Allen’s Institute for Brain Science to move to Seattle’s South Lake Union area

by John Cook on November 2, 2012November 3, 2012 at 9:04 pm

Seattle’s fast-growing South Lake Union neighborhood is getting another boost — this time from the guy who is largely responsible for its transformation. Paul Allen’s Institute for Brain Science announced today… Read More

Resolve Therapeutics lands $5.8M to crack the code on Lupus

by John Cook on November 1, 2012November 1, 2012 at 8:29 am

Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing from New Science Ventures, WRF Capital and Easton Capital. The company… Read More

Tech Moves: Amazon hires privacy officer; Blucora bolsters board; CTI’s new hire; and more

by John Cook on September 4, 2012September 4, 2012 at 8:33 am

TaxACT co-founder Lance Dunn has been appointed to the board of Blucora, the search and tax preparation company formerly known as InfoSpace. Blucora purchased TaxACT earlier this year for $287.5 million. “This is an exciting time… Read More

Dendreon shares sink after plant closure, restructuring

by John Cook on July 30, 2012July 30, 2012 at 6:48 pm

Dendreon, the once-promising Seattle biotechnology company, is taking it on the chin today after announcing a restructuring that will cost more than 600 people their jobs; the closure of its manufacturing… Read More

Tech Moves: Captura co-founder joins Point Inside; ISB; Cypress; Intrepid; etc.

by John Cook on June 13, 2012June 13, 2012 at 8:26 am

Point Inside, a Seattle startup that specializes in mapping indoor spaces, has named technology veteran Corey Mandell as CTO. Mandell most recently served as senior vice president of product engineering at… Read More

Can ultrasound reduce blood pressure? Kona Medical lands $30M to find out

by John Cook on May 30, 2012May 30, 2012 at 3:57 pm

The Seattle area continues to be a hotbed of innovation in the field of ultrasound technology, with news today that Kona Medical has attracted a $30 million round of venture… Read More

Kineta, UW receive biodefense grant to study ways to wipe out deadly viruses like Ebola

by John Cook on May 8, 2012May 8, 2012 at 12:51 pm

The University of Washington, University of Texas Medical Branch and Kineta — a Seattle biotechnology upstart — have received an $8.1 million grant from the National Institute of Allergy and Infectious… Read More

George Rathmann, 1927-2012: Biotech pioneer led Amgen and Icos

by John Cook on April 24, 2012April 24, 2012 at 5:28 am

George Rathmann, the biotechnology pioneer who served as the first CEO of Amgen and Icos, has died at the age of 84 from complications from pneumonia. Rathmann joined Amgen in… Read More

Alder BioPharma raises $38M for cancer, migraine research

by John Cook on April 19, 2012April 19, 2012 at 6:55 am

In one of the largest venture capital rounds in the state so far this year, Bothell’s Alder BioPharmaceuticals has raised $38 million to support ongoing research for its cancer and migraine… Read More

Tech Moves: RealNetworks VP joins Amazon’s Kindle team; etc.

by John Cook on January 6, 2012January 6, 2012 at 1:22 pm

Another day, another executive departure from RealNetworks. Yesterday, we reported that chief financial officer Michael Eggers — a 14-year veteran of the company — was stepping down. Now, we’ve gotten… Read More

MicroRNA startup Groove Biopharma scores $6 million

by John Cook on December 12, 2011December 12, 2011 at 7:38 am

It’s been a bit slow in Seattle venture capital circles in the past few months. But some of the region’s leading biotech investors are doing their part to pick up… Read More

Venture capitalist Thong Le tapped as chair of biotech group

by John Cook on October 7, 2011October 7, 2011 at 12:17 pm

Thong Le, the managing director of WRF Capital, has been named chairman of the Washington Biotechnology and Biomedical Association. Le was named vice chairman of the state’s leading biotechnology lobbying… Read More

Theraclone Sciences raises $10M

by John Cook on September 9, 2011September 9, 2011 at 11:40 am

Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors in the deal include ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare… Read More

Biotechnology